Allogene Therapeutics, Inc.ALLONASDAQ
Loading
EBITDA as a percentage of revenue
Latest
0.00%
↑ 100% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthStrong
Average
-182405.27%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00% | +100.0% |
| 2024 | -1106031.82% | -235.6% |
| 2023 | -329543.16% | -60.0% |
| 2022 | -205923.72% | -138311.1% |
| 2021 | -148.78% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |
| 2017 | 0.00% | - |